Search companies on Owler
Advanced Search
Latest news
Newsfeed
My followed companies
Followed Companies

HDB operates as a biology and preclinical drug discovery contract research organization. Read more

4 Followers on Owler
4 Followers on Owler
4 Followers on Owler
4 Followers on Owler

HDB operates as a biology and preclinical drug discovery contract research organization. Read more

Xuehai Tan's photo - Chairman & CEO of HD Biosciences

Chairman & CEO

Xuehai Tan

CEO Approval Rating

88/100

Founded:

2002

Status:

PrivateSubsidiary of WuXi AppTec Co., Ltd.

SIC Code:

2836 NAICS listing »

Est. Annual Revenue
Est. Employees
Sector
Biotechnology
Headquarters

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

HD Biosciences' top 9 competitors are Medicilon, Sundia MediTech Company, Ltd., GENEWIZ, Crystal Pharmatech, ChemPartner, Yaoyanshe, NGX Bio, Psomagen, Inc. and MOgene. Together they have raised over 157.1M between their estimated 3.1K employees. HD Biosciences's revenue is the ranked 5th among it's top 10 competitors. The top 10 competitors average 31.7M. HD Biosciences has 30 employees and is ranked 8th among it's top 10 competitors. The top 10 competitors average 314.

Medicilon is perceived as one of HD Biosciences's biggest rivals. Medicilon's headquarters is in Shanghai, Jiangsu Province, and was founded in 2004. Medicilon operates in the Biotechnology industry. Medicilon generates 234% of HD Biosciences's revenue.

Sundia MediTech Company, Ltd. has been one of HD Biosciences's top competitors. Sundia MediTech Company, Ltd. is a Private company that was founded in 2004 in Shanghai, Jiangsu Province. Sundia MediTech Company, Ltd. is in the Pharmaceuticals field. Compared to HD Biosciences, Sundia MediTech Company, Ltd. has 80 more employees.

GENEWIZ is HD Biosciences's #3 rival. GENEWIZ was founded in South Plainfield, New Jersey} in 1999. GENEWIZ operates in the Biotechnology industry. Compared to HD Biosciences, GENEWIZ generates $117.5M more revenue.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is $6.5M a good estimate for HD Biosciences's revenue?

I don't know

Acquisitions

No recent acquisitions found related to HD Biosciences

HD Biosciences Funding History

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Series A
Aug 2008
--

Morningside Venture

Since HD Biosciences was founded in 2002, it has participated in 1 round of funding. In total HD Biosciences has raised $0. HD Biosciences' funding round was on Aug 2008 for a total of $0

Investments

No recent investments found related to HD Biosciences

HD Biosciences News

June 20, 2018BioPortfolio

HD Biosciences China Co Ltd Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 12032018 Prices from USD $250

SummaryHD Biosciences China Co Ltd HDB a subsidiary of WuXi AppTec Co Ltd is a contract research orga... See more »
November 24, 2017BioPortfolio

HD Biosciences China Co Ltd Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 09112017 Prices from USD $250

SummaryHD Biosciences China Co Ltd HDB a subsidiary of WuXi AppTec Co Ltd is a contract research orga... See more »
February 9, 2017Biospectrum Asia

WuXi AppTec acquires HD Biosciences

Biospectrum The acquisition will strengthen WuXi's R&D capability from target validation to lead disc... See more »
January 23, 2017Outsourcing-Pharma

WuXi AppTec acquires preclinical CRO

WuXi AppTec has acquired Shanghai-based HD Biosciences (HDB), a biology-focused preclinical contract ... See more »
July 14, 2014CONTRACT PHARMA

HD Biosciences Enters Anti-cancer R&D Alliance

Aims to develop and commercialize drugs targeting international and Chinese markets... See more »
July 11, 2014PHARMACEUTICAL BUSINESS REVIEW

HD Biosciences, Marshall University enter drug discovery co-development deal

HD Biosciences, a China-based biology-focused preclinical drug discovery contract research organizati... See more »

HD Biosciences Press Releases

July 10, 2014PR NEWSWIRE

HD Biosciences and Marshall University Reach Drug Discovery Co-development Agreement

SHANGHAI, July 10, 2014 /PRNewswire/ -- HD Biosciences Co., Ltd. (HDB), the Marshall Institute for In... See more »

Social Media

Headquarters

590 Ruiqing Road Zhangjiang Hi-Tech Park East Campus

Pudong, Shanghai Municipality201201

86-21-5116-3700

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

HDB operates as a biology and preclinical drug discovery contract research organization. HD Biosciences was founded in 2002. HD Biosciences' headquarters is located in Pudong, Shanghai Municipality, CN 201201. It has raised undisclosed amount in 1 rou...

CEO

HD Biosciences's Chairman & CEO, Xuehai Tan, currently has an approval rating of 88%. HD Biosciences's primary competitors are Medicilon, Sundia MediTech Company, Ltd. & GENEWIZ.

Website

hdbiosciences.com

Frequently Asked Questions about HD Biosciences

  1. When was HD Biosciences founded?

    HD Biosciences was founded in 2002

  2. Who is HD Biosciences's CEO?

    HD Biosciences's CEO is Xuehai Tan

  3. How much revenue does HD Biosciences generate?

    HD Biosciences generates $6.5M in revenue

  4. How much funding does HD Biosciences have?

    HD Biosciences has historically raised $0 in funding

  1. Where is HD Biosciences's headquarters?

    HD Biosciences's headquarters is in Pudong Shanghai Municipality, CN

  2. How many employees does HD Biosciences have?

    HD Biosciences has 30 employees

  3. What sector does HD Biosciences operate in?

    HD Biosciences is in Biotechnology

  4. Who are HD Biosciences's competitors?

    HD Biosciences's top competitors are Medicilon, Sundia MediTech Company, Ltd., GENEWIZ
Stay up-to-date with the latest news on HD Biosciences

© 2021 Owler, Inc.